Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bilateral Quadratus Lumborum Block (QLB) is a regional anesthetic technique utilized for postoperative pain management, particularly following abdominal surgeries such as cesarean sections. In the clinical trial context provided by Mahidol University, the procedure involves the bilateral administration of a local anesthetic, specifically 0.25% bupivacaine, into the fascial plane surrounding the quadratus lumborum muscle. This technique facilitates the spread of the anesthetic into the paravertebral space, targeting the T5-L1 nerve branches to provide both somatic and visceral analgesia. The primary goal of the Bilateral QLB is to provide effective regional pain relief, thereby reducing the requirement for systemic opioids and minimizing associated side effects such as nausea, vomiting, and pruritus, while supporting earlier postoperative mobilization and recovery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bilateral Quadratus Lumborum Block.